CN Patent

CN1098120C — 微滴乳状液

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2003-01-08 · 23y expired

What this patent protects

本发明涉及一种微滴乳状液包括(1)一种或两种选自HLB为14或更大的硬脂酸十聚甘油(decaglycerol)酯和HLB为18或更大的硬脂酸蔗糖酯，(2)一种或两种选自HLB为13或更大的肉豆蔻酸十聚甘油酯和HLB为14或更大的月桂酸十聚甘油酯，(3)脂溶性组分，和(4)水溶性多元醇，其中(1)和(2)的重量比率为1∶0.5-1∶6。

USPTO Abstract

本发明涉及一种微滴乳状液包括(1)一种或两种选自HLB为14或更大的硬脂酸十聚甘油(decaglycerol)酯和HLB为18或更大的硬脂酸蔗糖酯，(2)一种或两种选自HLB为13或更大的肉豆蔻酸十聚甘油酯和HLB为14或更大的月桂酸十聚甘油酯，(3)脂溶性组分，和(4)水溶性多元醇，其中(1)和(2)的重量比率为1∶0.5-1∶6。

Drugs covered by this patent

Patent Metadata

Patent number
CN1098120C
Jurisdiction
CN
Classification
—
Expires
2003-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.